The packed audience at the Bracco-sponsored scientific symposium on MRI in oncology at this year’s ECR congress were treated to top-of-the-line presentations given by clinicians renowned in their field and who described the current status and future potential of MR imaging in prostate, breast and pancreas cancer respectively. A feature common to all presentations was the demonstration of the important role played by Contrast-Enhanced MR imaging in the different pathologies.